Ildong Pharmaceutical Co., Ltd.

KOSE:A249420 Stock Report

Market Cap: ₩339.7b

Ildong Pharmaceutical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Yun Paul Woongsup

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Revenues Not Telling The Story For Ildong Pharmaceutical Co., Ltd. (KRX:249420) After Shares Rise 33%

Aug 20
Revenues Not Telling The Story For Ildong Pharmaceutical Co., Ltd. (KRX:249420) After Shares Rise 33%

Is Ildong Pharmaceutical (KRX:249420) A Risky Investment?

Aug 12
Is Ildong Pharmaceutical (KRX:249420) A Risky Investment?

If You Had Bought Ildong Pharmaceutical (KRX:249420) Shares A Year Ago You'd Have Earned 18% Returns

Jan 01
If You Had Bought Ildong Pharmaceutical (KRX:249420) Shares A Year Ago You'd Have Earned 18% Returns

CEO

Yun Paul Woongsup

no data

Tenure

Yun Paul Woongsup is Chief Executive Officer of Ildong Pharmaceutical Co., Ltd.